Literature DB >> 6824954

Electrical stimulation of cerebellar fastigial nucleus increases cerebral cortical blood flow without change in local metabolism: evidence for an intrinsic system in brain for primary vasodilation.

M Nakai, C Iadecola, D A Ruggiero, L W Tucker, D J Reis.   

Abstract

We sought to determine whether the increase in regional cerebral blood flow (rCBF) elicited by electrical stimulation of the fastigial nucleus of the cerebellum (FN) is secondary to, or independent of, increased local cerebral metabolism (rGMR) in anesthetized (chloralose) paralyzed rats. rCBF and rGMR were determined autoradiographically in separate groups of animals with comparable blood gases and systemic pressure, by the [14C]iodoantipyrine and [14C]2-deoxyglucose methods respectively. In sham-operated controls, rCBF (n = 5) and rGMR (n = 5) were closely related in the 28 brain areas studied (r = 0.733; P less than 0.005). During FN stimulation, rCBF (n = 6) increased significantly in 24 of the 28 areas, the greatest increase being in the cerebral cortex (up to 215%). rGMR (n = 9) increased in only 15 areas, so that the correlation between rCBF and rGMR throughout the brain became weaker (r = 0.568; P less than 0.005). Where the rCBF increases were the greatest (particularly in the cerebral cortex), rGMR was unchanged. This suggests that the rCBF increase was not a consequence of the increased rGMR. We conclude that neurons originating in or passing through FN may influence local cerebral circulation through a primary cerebral vasodilatation not coupled to metabolism.

Entities:  

Mesh:

Year:  1983        PMID: 6824954     DOI: 10.1016/0006-8993(83)90762-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  Cerebellar connections to the dorsomedial and posterior nuclei of the hypothalamus in the rat.

Authors:  S Cavdar; T San; R Aker; U Sehirli; F Onat
Journal:  J Anat       Date:  2001-01       Impact factor: 2.610

Review 2.  Neurogenic neuroprotection.

Authors:  Eugene V Golanov; Ping Zhou
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

3.  The posterior hypothalamus is responsible for the increase of brain temperature during paradoxical sleep.

Authors:  M Denoyer; M Sallanon; C Buda; G Delhomme; A Dittmar; M Jouvet
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

Review 4.  Interconnections between hypothalamus and cerebellum.

Authors:  E Dietrichs; D E Haines
Journal:  Anat Embryol (Berl)       Date:  1989

5.  Evaluating the accuracy of perfusion/metabolism (SPET/PET) ratio in seizure localization.

Authors:  K Buch; H Blumenfeld; S Spencer; E Novotny; I G Zubal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-16       Impact factor: 9.236

6.  Modification of activity-dependent increases of cerebral blood flow by excitatory synaptic activity and spikes in rat cerebellar cortex.

Authors:  C Mathiesen; K Caesar; N Akgören; M Lauritzen
Journal:  J Physiol       Date:  1998-10-15       Impact factor: 5.182

7.  Focal elevations in neocortical interstitial K+ produced by stimulation of the fastigial nucleus in rat.

Authors:  C Iadecola; R P Kraig
Journal:  Brain Res       Date:  1991-11-01       Impact factor: 3.252

8.  Differential effects of methylxanthines on local cerebral blood flow and glucose utilization in the conscious rat.

Authors:  J J Grome; V Stefanovich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-06       Impact factor: 3.000

9.  Neurogenic neuroprotection: clinical perspectives.

Authors:  Mauricio Mandel; Erich Talamoni Fonoff; Edson Bor-Seng-Shu; Manoel Jacobsen Teixeira; Gerson Chadi
Journal:  Funct Neurol       Date:  2012 Oct-Dec

10.  Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology.

Authors:  R J Hargreaves; M Rigby; D Smith; R G Hill
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.